Integrated Filing — IndAS



General information about company

Scrip Code 590021
NSE Symbol BHARATRAS
MSEI Symbol NOTLISTED
ISIN INE838B01013
Name of company BHARAT RASAYAN LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 11-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment The Company operates only in one business segment viz. pesticides, hence segment wise reporting is not applicable.
Start date and time of board meeting 11-11-2025   14:00:00
End date and time of board meeting 11-11-2025   16:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 28,596.00 66,336.00
Other income 905.00 1,615.00
Total income 29,501.00 67,951.00
2 Expenses
(a) Cost of materials consumed 22,713.00 44,189.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (3,134.00) 52.00
(d) Employee benefit expense 2,277.00 4,468.00
(e) Finance costs 109.00 227.00
(f) Depreciation, depletion and amortisation expense 647.00 1,286.00
(f) Other Expenses
1 Other Expenses 3,433.00 7,003.00
Total other expenses 3,433.00 7,003.00
Total expenses 26,045.00 57,225.00
3 Total profit before exceptional items and tax 3,456.00 10,726.00
4 Exceptional items 0.00 1,478.00
5 Total profit before tax 3,456.00 12,204.00
6 Tax expense
7 Current tax 767.00 2,346.00
8 Deferred tax 73.00 (80.00)
9 Total tax expenses 840.00 2,266.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,616.00 9,938.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (172.00) 228.00
16 Total profit (loss) for period 2,444.00 10,166.00
17 Other comprehensive income net of taxes 3.00 6.00
18 Total Comprehensive Income for the period 2,447.00 10,172.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 0.00 0.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 0.00 0.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 415.52 415.52
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 67.1 162.54
Diluted earnings (loss) per share from continuing operations 67.1 162.54
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 67.1 162.54
Diluted earnings (loss) per share from continuing and discontinued operations 67.1 162.54
24 Debt equity ratio 0.00 0.00
25 Debt service coverage ratio 0.00 0.00
26 Interest service coverage ratio 0.00 0.00
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1) The above Consolidated financial results including Un-Audited Results of the Company and Un-Audited figures of JV Company namely M/s. Nissan Bharat Rasayan Pvt. Limited, for the quarter and six months ended September 30, 2025 have been reviewed by the Audit Committee and approved by the Board of Directors in its meeting held on November 11, 2025. The Statutory Auditors have carried out a limited review of these financial results. The Consolidated Financial Results will be available at the Website of the Company www.bharatgroup.co.in and National Stock Exchange of India Limited www.nseindia.com where the Company shares are listed. 2) The financial results of the Company have been prepared in accordance with Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with Companies Indian Accounting Standard Rules, 2015, as amended from time to time. 3) Corresponding quarter and financial year figures have been regrouped wherever considered necessary. 4) The Company operates only in one business segment viz. pesticides, hence segment wise reporting is not applicable. 5) The figures of quarter ended 30.09.2025 are the balancing figures between un-audited figures in respect of half year ended 30.09.2025 and the published year to date figures upto first quarter ended 30.06.2025. 6) The insurance claim process for damage to Property, Plant, and Equipment in Block-D of the Dahej Plant is currently underway. Accordingly, depreciation continues to be charged on the entire book value/written-down value of the assets, in accordance with the provisions of the Companies Act, 2013 and the Income Tax Act, 1961. The Company has implemented all appropriate safety measures to prevent the recurrence of such incidents in the future. Furthermore, with respect to the insurance claim for Loss of Profit, the Company will recognize the claim amount on a receipt basis.7) The Company is continued to maintain CARE AA- for Long Term Facilities and CARE A1+ for Short Term Facilities. 8) Joint Venture Performance: The Company Joint Venture, M/s Nissan Bharat Rasayan Private Limited, which is accounted for using the equity method under Ind AS, reported total revenue of Rs. 75.52 crore and a profit after tax of Rs. 5.74 crore for the quarter ended 30th September, 2025. The profit after tax includes a foreign exchange loss of Rs. 3.84 crore. The Company share of the Joint Venture net profit, amounting to Rs. 1.72 crore, has been recognized in the consolidated Statement of Profit and Loss. 9) The Company has designated an Email-ID viz. investors.brl@bharatgroup.co.in exclusively for the purpose of registering complaints by investors and for the redressal of investors grievance.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 22,323.00
Capital work-in-progress 2,476.39
Investment property 0.00
Goodwill 0.00
Other intangible assets 8.05
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 6,611.46
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets 202.35
Total non-current financial assets 6,813.81
Deferred tax assets (net) 0.00
Other non-current assets 445.76
Total non-current assets 32,067.01
2 Current assets
Inventories 29,862.04
Current financial asset
Current investments 23,143.31
Trade receivables, current 48,340.23
Cash and cash equivalents 4,728.66
Bank balance other than cash and cash equivalents 27.28
Loans, current 0.00
Other current financial assets 39.83
Total current financial assets 76,279.31
Current tax assets (net) 0.00
Other current assets 7,367.30
Total current assets 1,13,508.65
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,45,575.66
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 415.52
Other equity 1,19,283.55
Total equity attributable to owners of parent 1,19,699.07
Non controlling interest 0.00
Total equity 1,19,699.07
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 0.00
Total non-current financial liabilities 0.00
Provisions, non-current 374.40
Deferred tax liabilities (net) 1,446.31
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 1,820.71
Current liabilities
Current financial liabilities
Borrowings, current 9,044.12
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 12,028.29
Total Trade payable 12,028.29
Other current financial liabilities 2,193.63
Total current financial liabilities 23,266.04
Other current liabilities 313.78
Provisions, current 0.00
Current tax liabilities (Net) 476.06
Deferred government grants, Current 0.00
Total current liabilities 24,055.88
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 25,876.59
Total equity and liabilites 1,45,575.66
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (3.00) (6.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 3.00 6.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 12,204.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0.00
Adjustments for decrease (increase) in inventories (826.05)
Adjustments for decrease (increase) in trade receivables, current (6,416.95)
Adjustments for decrease (increase) in trade receivables, non-current 2,336.64
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets (430.71)
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,183.71)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (531.13)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,285.55
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (44.01)
Adjustments for provisions, non-current 174.10
Adjustments for other financial liabilities, current (172.21)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (691.66)
Adjustments for dividend income 0.00
Adjustments for interest income 7.46
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (1.94)
Other adjustments for non-cash items 6.10
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (7,503.44)
Net cash flows from (used in) operations 4,700.56
Dividends received 0.00
Interest paid (227.41)
Interest received 0.00
Income taxes paid (refund) 1,969.35
Other inflows (outflows) of cash (2,956.13)
Net cash flows from (used in) operating activities 2.49
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 5.20
Purchase of property, plant and equipment 1,619.68
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 8.57
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (133.41)
Net cash flows from (used in) investing activities (1,739.32)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings (522.20)
Payments of lease liabilities 0.00
Dividends paid 62.33
Interest paid 227.41
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 232.46
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1,504.37)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 691.66
Net increase (decrease) in cash and cash equivalents (812.71)
Cash and cash equivalents cash flow statement at beginning of period 5,541.37
Cash and cash equivalents cash flow statement at end of period 4,728.66